Welch Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-71,382
Closed -$8.36M 46
2017
Q4
$8.36M Sell
71,382
-103
-0.1% -$11.6K 2.98% 10
2017
Q3
$8.13M Sell
71,485
-2,647
-4% -$306K 2.74% 12
2017
Q2
$9.24M Sell
74,132
-15,388
-17% -$1.82M 3.06% 10
2017
Q1
$10.6M Sell
89,520
-15,821
-15% -$1.79M 3.5% 6
2016
Q4
$10.6M Buy
105,341
+23,865
+29% +$2.56M 3.57% 8
2016
Q3
$10.3M Sell
81,476
-4,552
-5% -$562K 3.35% 9
2016
Q2
$10.1M Sell
86,028
-89,542
-51% -$10.1M 3.62% 13
2016
Q1
$18.2M Sell
175,570
-7,624
-4% -$738K 6.65% 1
2015
Q4
$18.2M Sell
183,194
-23,422
-11% -$2.29M 6.16% 2
2015
Q3
$18.8M Buy
206,616
+17,963
+10% +$1.8M 6.41% 1
2015
Q2
$20M Buy
188,653
+333
+0.2% +$36.8K 5.96% 1
2015
Q1
$21.5M Buy
188,320
+32,476
+21% +$3.71M 6.97% 1
2014
Q4
$17.2M Hold
155,844
5.43% 4
2014
Q3
$15.2M Buy
+155,844
New +$15.3M 5% 4

Other funds holding ZBH

Welch Capital Partners's ZBH Position: Q1 2018 in Review

Welch Capital Partners sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 71,382 shares — an estimated $8.36M sold.

Welch Capital Partners first reported a position in ZBH in Q3 2014 and held it in 14 quarters. The position peaked at $21.5M in Q1 2015. 876 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

  • Welch Capital Partners reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
  • Welch Capital Partners sold 71,382 Zimmer Biomet shares in Q1 2018, an estimated $8.36M.
  • Welch Capital Partners first reported a position in Zimmer Biomet in Q3 2014 and held it in 14 quarters.
  • Welch Capital Partners's Zimmer Biomet position peaked at $21.5M in Q1 2015.
  • 876 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Welch Capital Partners's 13F filing for Q1 2018, filed 9 May 2018.